InnovAge Holding Corp. (INNV)
| Market Cap | 1.26B +76.9% |
| Revenue (ttm) | 989.71M +15.9% |
| Net Income | -2.54M |
| EPS | -0.02 |
| Shares Out | 136.45M |
| PE Ratio | n/a |
| Forward PE | 21.05 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 271,390 |
| Open | 9.56 |
| Previous Close | 9.55 |
| Day's Range | 9.25 - 9.66 |
| 52-Week Range | 3.94 - 12.64 |
| Beta | 0.15 |
| Analysts | Hold |
| Price Target | 12.00 (+29.45%) |
| Earnings Date | Nov 3, 2026 |
About INNV
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments... [Read more]
Financial Performance
In fiscal year 2026, InnovAge Holding's revenue was $989.71 million, an increase of 15.93% compared to the previous year's $853.70 million. Losses were -$2.54 million, -91.63% less than in 2025.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for INNV stock is "Hold." The 12-month stock price target is $12.0, which is an increase of 29.45% from the latest price.
News
InnovAge Holding Proxy statement: Proxy filing
InnovAge Holding filed a proxy statement on October 22, 2026, providing details for shareholder voting and corporate governance matters.
InnovAge Holding Proxy statement: Proxy filing
InnovAge Holding filed a proxy statement on October 22, 2026, providing details for shareholder voting and corporate governance matters.
InnovAge to Announce Fiscal First Quarter 2027 Financial Results and Host Conference Call Tuesday, November 3, 2026
DENVER, Oct. 20, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predomina...
InnovAge Announces Pricing of Secondary Offering of Common Stock by Selling Stockholders
DENVER, Sept. 22, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantl...
InnovAge announces offering of 10M shares of common stock for holders
InnovAge (INNV) announced the launch of an underwritten public offering of its common stock by investment funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe. The selling stockhold...
InnovAge Announces Launch of Proposed Secondary Offering of Common Stock by Selling Stockholders
DENVER, Sept. 22, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantl...
InnovAge Holding Transcript: Wells Fargo 21st Annual Healthcare Conference
The platform has evolved through significant transformation, now delivering integrated, value-based care for complex seniors with consistent financial growth and expanding margins. Long-term growth is supported by under-penetrated market opportunities, policy tailwinds, and pragmatic AI adoption. 2027 guidance targets $105–$115 million adjusted EBITDA, with a focus on sustainable margins.
InnovAge Holding Slides: Wells Fargo 21st Annual Healthcare Conference
InnovAge Holding has posted slides in relation to its latest quarterly earnings report, which was published on September 9, 2026.
InnovAge price target raised to $14 from $13 at KeyBanc
KeyBanc raised the firm’s price target on InnovAge (INNV) to $14 from $13 and keeps an Overweight rating on the shares. The firm believes Q4 results were impressive, highlighted by…
InnovAge Holding Earnings Call Transcript: Q4 2026
Fiscal 2026 saw strong growth in revenue, adjusted EBITDA, and operational efficiency, with margin expansion and improved participant outcomes. Fiscal 2027 guidance targets continued census and revenue growth, disciplined margin management, and further technology-driven efficiencies. Fiscal risks include unresolved state rates and ongoing regulatory changes.
InnovAge Holding Earnings release: Q4 2026
InnovAge Holding released its Q4 2026 earnings on September 8, 2026, summarizing the period's financial results.
InnovAge Holding Prepared remarks: Q4 2026
InnovAge Holding filed a regulatory document on September 8, 2026 disclosing important business information.
InnovAge Holding Annual report: Q4 2026
InnovAge Holding has published its Q4 2026 annual report on September 8, 2026.
InnovAge Holding Annual report: Q4 2026
InnovAge Holding has published its Q4 2026 annual report on September 8, 2026.
InnovAge reports Q4 EPS 6c, consensus 8c
Reports Q4 revenue $261.95M, consensus $238.27M. “Fiscal 2026 was an exceptional year for InnovAge (INNV) and reflects the significant progress we have made strengthening the company,” said Patrick Bl...
InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026
DENVER, Sept. 08, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantl...
InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conference
DENVER, Aug. 26, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predomina...
InnovAge upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc upgraded InnovAge (INNV) to Overweight from Sector Weight with a $13 price target after meeting with management. While the company’s turnaround is complete, it has “significant opportunities” ...
InnovAge files to sell 112.99M shares of common stock for holders
16:12 EDT InnovAge (INNV) files to sell 112.99M shares of common stock for holders
InnovAge Holding Registration statement: Registration filing
InnovAge Holding filed a registration statement on July 31, 2026, providing details about a securities offering with the SEC.
InnovAge Holding Slides: Corporate presentation
InnovAge Holding has posted slides in relation to its latest quarterly earnings report, which was published on May 16, 2026.
InnovAge names Jennifer Browne COO
InnovAge (INNV) announced that Jennifer Browne has been appointed president and COO, effective June 8. Most recently, she served as the COO for Strive Health overseeing market operations and shared…
InnovAge Appoints Jennifer Browne as President and Chief Operating Officer
DENVER, May 12, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly ...
InnovAge Holding Earnings Call Transcript: Q3 2026
Q3 saw strong revenue and margin growth, driven by higher capitation rates and improved operational execution, despite a net loss from increased litigation liability. Fiscal 2026 guidance was raised, but 2027 faces rate pressures; investments in AI and quality are expected to support long-term growth.
InnovAge Holding Earnings release: Q3 2026
InnovAge Holding released its Q3 2026 earnings on May 5, 2026, summarizing the period's financial results.